“[The] patient seems to have made a full recovery with no ill effects that we are aware of and is able to control the mouse, move the mouse around the screen just by thinking,” Mr. Musk said during a live audio Spaces session on social media platform X.
Neuralink, Mr. Musk’s neurotechnology company, implanted the chip into the first patient in January. Neuralink did not respond to CNBC’s request for comment.
The company was founded in 2017 and aims to use a chip implanted in the brain to help humans use their neural signals to control external technologies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
